| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 90,274,000 | 34.56% | ||
| 2 | OPHTHOTECH CORP COM | 1,397,256 | 72,742,000 | 27.85% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,932,607 | 40,643,000 | 15.56% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,857,667 | 34,892,000 | 13.36% | ||
| 5 | TRANSENTERIX INC | 7,546,692 | 22,640,000 | 8.67% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008669, filed 2015.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
